• Biogen (BIIB) and Stoke Release Results from Dravet Syndrome Stu GuruFocus Mon, 17 Nov 2025 13:33:15 GMT
• Biogen (BIIB) Reveals Key Findings from Dravet Syndrome Study GuruFocus Mon, 17 Nov 2025 13:33:13 GMT
• Biogen Says EU Committee Recommends Approval of High Dose Nusinersen Regimen MarketScreener Mon, 17 Nov 2025 13:01:18 GMT
• The next leap in Alzheimer’s R&D is coming, but not around the corner PharmaVoice Mon, 17 Nov 2025 12:46:42 GMT
• Stoke Therapeutics and Biogen Announce Publication of Two-Year Natural History Data Demonstrating the Severity of Dravet Syndrome,... Yahoo Finance Mon, 17 Nov 2025 12:30:00 GMT
• Biogen (Nasdaq: BIIB) and Stoke 2-Year Dravet Study Shows Plateaued Development Stock Titan Mon, 17 Nov 2025 12:30:00 GMT
• Biogen (BIIB) Advances High Dose Spinal Muscular Atrophy Treatme GuruFocus Mon, 17 Nov 2025 11:34:53 GMT
• Biogen Receives Positive CHMP Opinion for High Dose Regimen of Nusinersen in Treating Spinal Muscular Atrophy Quiver Quantitative Mon, 17 Nov 2025 11:12:00 GMT
• Biogen acquires Alcyone to boost CNS drug delivery Medical Device Network Mon, 17 Nov 2025 10:29:03 GMT
• Parkinson's Disease Market Set for Dynamic Rise with Key Players openPR.com Mon, 17 Nov 2025 07:08:14 GMT
• Biogen Receives Dual Boost for Alzheimer’s Treatment Strategy AD HOC NEWS Mon, 17 Nov 2025 06:55:04 GMT
• fund update: 282,084 biogen (biib) shares added to zurcher kantonalbank (zurich cantonalbank) portfolio Quiver Quantitative Fri, 14 Nov 2025 21:15:00 GMT
• biogen stock hits 52-week high at 167.87 usd by investing.com Investing.com India Fri, 14 Nov 2025 16:28:22 GMT
• mhra approves leqembi iv maintenance as additional alzheimer’s option European Pharmaceutical Review Fri, 14 Nov 2025 14:04:41 GMT
• Biogen (BIIB) Gains UK Approval for LEQEMBI Maintenance Dosing GuruFocus Fri, 14 Nov 2025 11:53:33 GMT
• Eisai and Biogen report Leqembi’s MHRA approval for Alzheimer’s Yahoo Fri, 14 Nov 2025 10:07:13 GMT
• eisai and biogen's leqembi® receives approval for once every four weeks iv maintenance dosing in the uk Quiver Quantitative Thu, 13 Nov 2025 23:40:00 GMT
• biogen at td cowen summit: strategic focus on i&i and kidney innovation Investing.com Thu, 13 Nov 2025 23:22:14 GMT
• biogen (biib) valuation in focus following q3 2025 results and key medical conference updates simplywall.st Thu, 13 Nov 2025 20:37:45 GMT
• shine a light on healthcare etfs amid national alzheimer's awareness month TradingView Thu, 13 Nov 2025 13:07:00 GMT
• taking the pulse, a health care and life sciences video podcast | episode 257: biogen’s $2b investment in north carolina’s rtp wit... JD Supra Tue, 11 Nov 2025 21:13:32 GMT
• does biogen pharmachem industries limited have a competitive advantage in its sector - fibonacci extensions & outstanding growth o... earlytimes.in Tue, 11 Nov 2025 13:42:07 GMT
• biogen at wedbush asn 2025: new horizons in kidney disease treatment Investing.com Mon, 10 Nov 2025 20:31:01 GMT
• novel techniques that beat traditional methods and help patients PharmTech.com Mon, 10 Nov 2025 19:33:23 GMT
• how biogen’s (biib) strong q3 earnings and new product growth could shape its investment outlook simplywall.st Mon, 10 Nov 2025 15:24:50 GMT
• alzheimer’s drug uptake hits its stride after a sluggish start PharmaVoice Mon, 10 Nov 2025 12:56:46 GMT
• is biogen worth a fresh look after major drug approvals in 2025? simplywall.st Sun, 09 Nov 2025 14:48:45 GMT
• Should Biogen’s (BIIB) Surging New Drug Sales Reshape Investors’ Expectations for Future Growth? Yahoo Finance Sat, 08 Nov 2025 08:00:00 GMT
• biogen shares recover slightly amid clinical trial partnerships — is the stock trading below fair value? Yahoo Finance UK Fri, 07 Nov 2025 03:17:00 GMT
• biogen (biib) valuation in focus after q3 earnings growth and share buyback update simplywall.st Thu, 06 Nov 2025 19:40:02 GMT
• here are thursday’s top wall street analysts research calls: amazon.com, biogen, caterpillar, e.l.f. beauty, southern company and ... Yahoo Finance Thu, 06 Nov 2025 14:02:18 GMT
• stifel upgrades biogen (biib) to 'buy', raises price target to $202 | biib stock news GuruFocus Thu, 06 Nov 2025 13:38:20 GMT
• will biogen inc. stock benefit from upcoming earnings reports - risk management & technical pattern based signals fcp.pa.gov.br Thu, 06 Nov 2025 12:55:39 GMT
• stifel upgrades biotech stock on a narrative shift in alzheimer’s treatment CNBC Thu, 06 Nov 2025 12:53:45 GMT
• stifel lifts biogen to buy, sees potential alzheimer’s narrative shift Investing.com Thu, 06 Nov 2025 12:30:15 GMT
• stifel upgrades biogen to buy from hold, adjusts price target to $202 from $144 MarketScreener Thu, 06 Nov 2025 11:29:50 GMT
• exclusive: lilly expects us medicare to reverse course, fully cover alzheimer's drugs Reuters Thu, 06 Nov 2025 10:23:49 GMT
• here are thursday's top wall street analysts research calls: amazon.com, biogen, caterpillar, e.l.f. beauty, southern company and ... 24/7 Wall St. Thu, 06 Nov 2025 08:02:18 GMT
• Biogen Trying To Close In On Key Technical Measure Investor's Business Daily Thu, 06 Nov 2025 08:00:00 GMT
• biogen shares recover slightly amid clinical trial partnerships — is the stock trading below fair value? Yahoo Finance Thu, 06 Nov 2025 08:00:00 GMT
• why biogen inc. (idp) stock stays on top picks - 2025 key highlights & reliable intraday trade plans fcp.pa.gov.br Thu, 06 Nov 2025 07:05:43 GMT
• why biogen inc. stock is seen as undervalued - weekly profit recap & free fast entry momentum trade alerts fcp.pa.gov.br Thu, 06 Nov 2025 07:00:59 GMT
• 5 insightful analyst questions from biogen’s q3 earnings call Yahoo Finance Thu, 06 Nov 2025 05:38:00 GMT
• why biogen inc. (idp) stock stays on top picks - weekly stock summary & real-time market sentiment reports fcp.pa.gov.br Wed, 05 Nov 2025 19:19:59 GMT
• biogen fights to defend ms franchise amid generic erosion and biosimilar threats Citeline News & Insights Wed, 05 Nov 2025 16:37:09 GMT
• biogen (nasdaq:biib) stock price expected to rise, mizuho analyst says MarketBeat Wed, 05 Nov 2025 14:31:30 GMT
• $185 million, proven team lead startup braveheart bio's toward late-stage heart drug trial The Business Journals Wed, 05 Nov 2025 12:58:00 GMT
• bnp paribas asset management holding s.a. boosts stake in biogen inc. $biib MarketBeat Wed, 05 Nov 2025 11:42:54 GMT
• cardio biotech braveheart gets $185m, names biogen ceo as its chair Endpoints News Wed, 05 Nov 2025 11:00:00 GMT
• retirement systems of alabama cuts holdings in biogen inc. $biib MarketBeat Wed, 05 Nov 2025 09:08:56 GMT
• 5 Insightful Analyst Questions From Biogen’s Q3 Earnings Call Yahoo Finance Wed, 05 Nov 2025 08:00:00 GMT
• braveheart bio launches with mission to conquer heart disease market, capturing $185m series a Fierce Biotech Wed, 05 Nov 2025 08:00:00 GMT
• canada gives conditional ok to early alzheimer’s drug leqembi Alzheimer's News Today Tue, 04 Nov 2025 21:34:50 GMT
• stoke therapeutics q3 revenue beats estimates on acadia, biogen agreements MarketScreener Tue, 04 Nov 2025 21:24:50 GMT
• biogen participating in the td cowen immunology & inflammation summit Biogen Tue, 04 Nov 2025 21:07:05 GMT
• bank of america securities sticks to their hold rating for biogen (biib) The Globe and Mail Tue, 04 Nov 2025 17:56:50 GMT
• sanford c. bernstein forecasts strong price appreciation for biogen (nasdaq:biib) stock MarketBeat Tue, 04 Nov 2025 13:17:16 GMT
• a quick look at today's ratings for biogen(biib.us), with a forecast between $167 to $194 富途牛牛 Tue, 04 Nov 2025 13:00:01 GMT
• biogen inc. $biib shares sold by ia global asset management inc. MarketBeat Tue, 04 Nov 2025 10:15:21 GMT
• bernstein maintains biogen (biib) market perform recommendation Nasdaq Tue, 04 Nov 2025 00:10:00 GMT
• bofa securities maintains biogen(biib.us) with hold rating, maintains target price $167 富途牛牛 Mon, 03 Nov 2025 17:45:58 GMT
• biogen’s hold rating: balancing promising growth with revenue challenges and infrastructure development TipRanks Mon, 03 Nov 2025 17:09:44 GMT
• biib: bernstein raises price target for biogen to $157 with mark GuruFocus Mon, 03 Nov 2025 13:39:19 GMT
• biogen to present felzartamab data at kidney week 2025 Investing.com Mon, 03 Nov 2025 13:38:06 GMT
• biogen (biib) reveals new data on felzartamab at kidney week 202 GuruFocus Mon, 03 Nov 2025 13:31:35 GMT
• bernstein raises biogen stock price target to $157 on ms franchise beat Investing.com Mon, 03 Nov 2025 13:22:00 GMT
• biogen inc. to present groundbreaking longitudinal gene expression data on felzartamab at kidney week 2025 Quiver Quantitative Mon, 03 Nov 2025 12:43:00 GMT
• Biogen to Highlight Scientific Progress in Rare Kidney Disease at American Society of Nephrology (ASN) Kidney Week 2025 Biogen Mon, 03 Nov 2025 12:32:09 GMT
• plato investment management ltd raises stock holdings in biogen inc. $biib MarketBeat Mon, 03 Nov 2025 10:03:39 GMT
• fy2025 eps estimates for biogen decreased by leerink partnrs MarketBeat Mon, 03 Nov 2025 07:15:15 GMT
• korea's samsung bioepis gains full rights to byooviz biosimilar from biogen in europe BioSpectrum Asia Mon, 03 Nov 2025 06:08:46 GMT
• biogen (nasdaq:biib) stock price expected to rise, wells fargo & company analyst says MarketBeat Sun, 02 Nov 2025 14:38:49 GMT
• guggenheim increases biogen (nasdaq:biib) price target to $185.00 MarketBeat Sun, 02 Nov 2025 14:38:28 GMT
• biogen (nasdaq:biib) given new $150.00 price target at bmo capital markets MarketBeat Sun, 02 Nov 2025 14:35:27 GMT
• biotech investments market seeking excellent growth | biogen (us), moderna, johnson & johnson openPR.com Sun, 02 Nov 2025 13:53:45 GMT
• how a strong q3 and increased r&d spending at biogen (biib) has changed its investment story simplywall.st Sun, 02 Nov 2025 13:44:38 GMT
• biogen shares drop as full-year guidance cut outweighs strong q3 results MSN Sun, 02 Nov 2025 12:56:59 GMT
• savvy advisors inc. buys new holdings in biogen inc. $biib MarketBeat Sun, 02 Nov 2025 09:29:54 GMT
• biogen inc. $biib stock holdings increased by wealthfront advisers llc MarketBeat Sun, 02 Nov 2025 08:31:43 GMT
• biogen (nasdaq:biib) stock rating lowered by wall street zen MarketBeat Sun, 02 Nov 2025 05:15:45 GMT
• what to expect from myriad genetics’s (mygn) q3 earnings TradingView Sun, 02 Nov 2025 03:07:00 GMT
• biogen’s earnings call highlights robust growth and positive outlook The Globe and Mail Sun, 02 Nov 2025 00:34:00 GMT
• royal bank of canada lowers biogen (nasdaq:biib) price target to $210.00 MarketBeat Sat, 01 Nov 2025 13:47:37 GMT
• biogen (nasdaq:biib) price target cut to $250.00 by analysts at robert w. baird MarketBeat Sat, 01 Nov 2025 13:47:36 GMT
• fjarde ap fonden fourth swedish national pension fund has $3.44 million stake in biogen inc. $biib MarketBeat Sat, 01 Nov 2025 08:24:38 GMT
• biogen’s earnings call highlights robust growth and positive outlook TipRanks Sat, 01 Nov 2025 01:05:49 GMT
• bmo capital adjusts biogen price target to $150 from $128 MarketScreener Fri, 31 Oct 2025 16:25:41 GMT
• biogen tops quarterly profit estimates, eyes deals to build early-stage pipeline MSN Fri, 31 Oct 2025 16:17:09 GMT
• biogen’s strategic advancements and diversification drive buy rating TipRanks Fri, 31 Oct 2025 15:51:09 GMT
• biogen (biib) rating maintained as rbc capital lowers price targ GuruFocus Fri, 31 Oct 2025 15:09:54 GMT
• biogen’s market challenges and opportunities: hold rating amid competitive pressures and strategic uncertainties TipRanks Fri, 31 Oct 2025 14:45:32 GMT
• biib q3 deep dive: new product launches offset guidance cut, r&d pipeline expands The Globe and Mail Fri, 31 Oct 2025 14:15:00 GMT
• wedbush raises price target on biogen to $143 from $135, keeps neutral rating MarketScreener Fri, 31 Oct 2025 13:58:28 GMT
• wells fargo adjusts price target on biogen to $155 from $140 MarketScreener Fri, 31 Oct 2025 13:41:43 GMT
• baird adjusts price target on biogen to $250 from $255 MarketScreener Fri, 31 Oct 2025 13:16:17 GMT
• biogen’s balanced risk-reward scenario: hold rating amidst strong legacy performance and strategic challenges TipRanks Fri, 31 Oct 2025 11:47:57 GMT
• rbc cuts price target on biogen to $210 from $217, keeps outperform rating MarketScreener Fri, 31 Oct 2025 11:16:09 GMT
• baird lowers biogen stock price target to $250 on slow launch product growth Investing.com Fri, 31 Oct 2025 10:22:28 GMT
• emerald advisers llc makes new investment in biogen inc. $biib MarketBeat Fri, 31 Oct 2025 10:21:49 GMT
• biogen lowers outlook even as profits and sales top estimates Finimize Fri, 31 Oct 2025 09:49:57 GMT
• biogen stock price target raised to $185 from $165 at guggenheim Investing.com Fri, 31 Oct 2025 08:42:43 GMT
• biogen (biib): one-time $471m loss raises fresh doubts over rebounding profit narrative Yahoo Finance Fri, 31 Oct 2025 07:00:00 GMT
• biogen’s resilient performance and growth prospects justify buy rating TipRanks Fri, 31 Oct 2025 05:04:29 GMT
• an early-career stand proved this young biotech exec had what it takes BioSpace Fri, 31 Oct 2025 04:57:26 GMT
• biogen (biib) valuation: exploring the discount as investor sentiment shifts Yahoo Finance Fri, 31 Oct 2025 04:25:00 GMT
• biogen’s innovative approach to sma treatment: a study update TipRanks Fri, 31 Oct 2025 04:15:40 GMT
• biogen (biib) net margin surges to 15.3%, challenging bearish profitability narratives after one-off loss simplywall.st Fri, 31 Oct 2025 00:46:04 GMT
• biogen lowers outlook even as profits and sales top estimates Finimize Thu, 30 Oct 2025 22:39:30 GMT
• biogen (biib) lowers full-year eps outlook despite strong q3 res GuruFocus Thu, 30 Oct 2025 20:24:26 GMT
• biib beats on q3 earnings & sales, stock down on lowered '25 eps view Yahoo Finance Thu, 30 Oct 2025 18:02:00 GMT
• biogen shares drop as full-year guidance cut outweighs strong q3 results MSN Thu, 30 Oct 2025 16:12:50 GMT
• samsung bioepis gains full rights to lucentis and eylea biosimilars in europe Citeline News & Insights Thu, 30 Oct 2025 15:41:18 GMT
• earnings call transcript: biogen q3 2025 beats forecasts, stock dips Investing.com Thu, 30 Oct 2025 15:16:10 GMT
• biogen cuts profit guidance following alcyone, vanqua deals FirstWord Pharma Thu, 30 Oct 2025 15:15:18 GMT
• As Biogen Nears Presymptomatic Alzheimer’s Readout for Leqembi, Can Doctors Be Convinced? BioSpace Thu, 30 Oct 2025 14:33:54 GMT
• biogen’s market challenges and opportunities: hold rating amid competitive pressures and strategic uncertainties TipRanks Thu, 30 Oct 2025 14:26:02 GMT
• biogen inc. reports earnings results for the third quarter and nine months ended september 30, 2025 MarketScreener Thu, 30 Oct 2025 13:51:52 GMT
• tranche update on biogen inc.'s equity buyback plan announced on october 21, 2020. MarketScreener Thu, 30 Oct 2025 13:51:43 GMT
• biogen’s strong financial performance and strategic positioning justify buy rating TipRanks Thu, 30 Oct 2025 13:33:31 GMT
• biogen q3 2025 earnings: beats revenue and profit estimates - news and statistics IndexBox Thu, 30 Oct 2025 13:18:00 GMT
• biogen's growth drivers hit third-quarter snags; why this isn't a 'fundamental' problem MSN Thu, 30 Oct 2025 12:59:47 GMT
• biogen sinks back into a buy zone after cutting its profit guide MSN Thu, 30 Oct 2025 12:59:47 GMT
• biogen lifts q3 revenue, trims full-year outlook on deal costs The Pharma Letter Thu, 30 Oct 2025 12:56:39 GMT
• biogen reports an 18% increase in adjusted quarterly eps MarketScreener Thu, 30 Oct 2025 12:32:30 GMT
• biogen stock slides on q3 beat as guidance cut shocks investors ts2.tech Thu, 30 Oct 2025 12:18:45 GMT
• biogen expects 2025 total revenue about flat to increasing 1%, at constant currency MarketScreener Thu, 30 Oct 2025 11:09:36 GMT
• biogen earnings beat by $0.93, revenue topped estimates Investing.com Thu, 30 Oct 2025 10:59:26 GMT
• biogen q3 beats market, cuts fy25 earnings view below street - update Nasdaq Thu, 30 Oct 2025 10:53:00 GMT
• biogen shares slide as guidance cut overshadows q3 earnings beat by investing.com Investing.com Canada Thu, 30 Oct 2025 10:52:49 GMT
• biogen inc (biib) q3 earnings: eps of $3.17 beats estimates, rev GuruFocus Thu, 30 Oct 2025 10:46:19 GMT
Biogen Inc(NASDAQ:BIIB) 
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases worldwide. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to ...
Website: http://www.biogen.com
Founded: 1978
Full Time Employees: 7,400
Sector: Healthcare
Industry: Drug Manufacturers-General